Jie Gan
Corporate Officer/Principal chez The Hong Kong University of Science & Technology
Postes actifs de Jie Gan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The Hong Kong University of Science & Technology | Corporate Officer/Principal | - | - |
Historique de carrière de Jie Gan
Anciens postes connus de Jie Gan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
China Biologic Products, Inc.
 China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | - | 08/01/2010 |
Formation de Jie Gan
| Peking University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 2 |
| Hong Kong | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
